Outcomes during and after long-term tocilizumab treatment in patients with giant cell arteritis.
- DOI
- 10.1136/rmdopen-2022-002923
- Published
- 2023 Apr
- Container
- RMD open
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1136/rmdopen-2022-002923,
title = {Outcomes during and after long-term tocilizumab treatment in patients with giant cell arteritis.},
author = {Matza MA and Dagincourt N and Mohan SV and Pavlov A and Han J and Stone JH and Unizony SH},
year = {2023},
journal = {RMD open},
doi = {10.1136/rmdopen-2022-002923},
url = {https://doi.org/10.1136/rmdopen-2022-002923}
}RIS
TY - JOUR TI - Outcomes during and after long-term tocilizumab treatment in patients with giant cell arteritis. AU - Matza MA AU - Dagincourt N AU - Mohan SV AU - Pavlov A AU - Han J AU - Stone JH AU - Unizony SH PY - 2023 JO - RMD open DO - 10.1136/rmdopen-2022-002923 UR - https://doi.org/10.1136/rmdopen-2022-002923 ER -
APA
MA, M., N, D., SV, M., A, P., J, H., JH, S., & SH, U. (2023). Outcomes during and after long-term tocilizumab treatment in patients with giant cell arteritis.. RMD open. https://doi.org/10.1136/rmdopen-2022-002923
Source records
- pubmed · retrieved 2026-09-27T12:07:40.721Z